• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Computational Analysis of Interleukin-4 and its Potency As a Therapy for Autoimmune Diseases

Undergraduate #22
Discipline: Biological Sciences
Subcategory: Chemical/Bimolecular/Process Engineering
Session: 4
Room: Exhibit Hall

Tyrece Emeil Frater - University of South Florida
Co-Author(s): Dr. Laurence A. Stern, University of South Florida, Florida



Interleukin(IL-4) is a cytokine that initiates type 2 helper-T cell pathways and mediates lymphocyte differentiation. Interleukin-4 is prized for its ability to suppress pro-inflammatory responses. Interleukin-4 is not a heavily engineered protein despite its notable impact in relieving autoimmune diseases such as psoriasis (Yang et. Al). Our approach to interleukin-4 was to increase its affinity for interaction without jeopardizing its stability. If we can increase the ligand’s affinity for interaction, then we can engineer a mutant IL-4 that will relieve these autoimmune diseases to a greater extent. We ran a command called Analyse Complex to understand the thermodynamic values that constitute interleukin-4. These values are important because it is no use to engineer a brilliant protein that cannot withstand the body’s internal environment. We ran two commands called Position Specific Scoring Matrix(PSSM) and Build Model. These commands applied mutagenesis to interleukin-4’s ligand, and receptor. Position Specific Scoring Matrix mutated the amino acids on the ligand that interact with the receptor. Build Model mutated the thermodynamic values of the non-interacting amino acids found on the receptor. After mutation, the thermodynamic values of a protein change, as did ours. We used this data to create heat maps in Microsoft Excel that allowed us to target segments of our cytokine that are suitable for bioengineering. Our heat map results from PSSM suggest that we may not be able to improve IL-4’s affinity for interaction without compromising structure. Our results from Build Model suggest that there are many mutations that we can make to IL4’s non-binding interface to improve its potency as a therapy for autoimmune diseases. Collectively, our results provide great incentive for further research.

Funder Acknowledgement(s): This research was funded by the National Science Foundation Research Experience for Undergraduates program Award Number 1950458. This opportunity was possible because of the work of LSAMP senior specialist Mr. John Fynn. This research is supported through a grant from the National Science Foundation under the Louis Stokes Alliances for Minority Participation (LSAMP) Program, HRD-1712683, 2017-2020.

Faculty Advisor: Dr. Laurence A. Stern, sternl@usf.edu

Role: I completed the entirety of this research with the verbal guidance of my professor, Dr. Lawrence A. Stern.

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science